Jacobs Levy Equity Management Inc. Cuts Stock Holdings in UiPath, Inc. $PATH

Key Points

• Jacobs Levy Equity Management Inc. reduced its position in UiPath, Inc. by 5.6% during the 1st quarter, now owning approximately 5.15 million shares valued at $53.08 million.
• Insiders, including CEO Daniel Dines and CFO Ashim Gupta, have sold a total of 831,310 shares worth over $10 million in the last 90 days.
• Wall Street analysts have upgraded UiPath's stock from a "buy" to a "strong-buy" rating, with a consensus target price of $13.25.

Jacobs Levy Equity Management Inc. lowered its stake in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 5.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,153,603 shares of the company's stock after selling 305,468 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 0.93% of UiPath worth $53,082,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of PATH. Versant Capital Management Inc lifted its stake in shares of UiPath by 198.6% in the first quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock worth $31,000 after buying an additional 1,970 shares in the last quarter. CX Institutional bought a new position in shares of UiPath in the first quarter worth approximately $36,000. Brooklyn Investment Group lifted its stake in shares of UiPath by 314.3% in the first quarter. Brooklyn Investment Group now owns 4,508 shares of the company's stock worth $46,000 after buying an additional 3,420 shares in the last quarter. National Bank of Canada FI bought a new position in shares of UiPath in the first quarter worth approximately $72,000. Finally, MRP Capital Investments LLC bought a new position in shares of UiPath in the first quarter worth approximately $82,000. Hedge funds and other institutional investors own 62.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on PATH. BMO Capital Markets dropped their target price on shares of UiPath from $15.50 to $12.50 and set a "market perform" rating on the stock in a research note on Friday. Cowen restated a "hold" rating on shares of UiPath in a research report on Friday. Truist Financial lowered their price objective on shares of UiPath from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday. Morgan Stanley increased their price objective on shares of UiPath from $12.00 to $15.00 and gave the company an "equal weight" rating in a research report on Monday, June 2nd. Finally, Evercore ISI increased their price objective on shares of UiPath from $11.00 to $15.00 and gave the company an "in-line" rating in a research report on Friday, May 30th. Two equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $13.18.

Insider Activity at UiPath

In other news, CEO Daniel Dines sold 9,988 shares of the firm's stock in a transaction on Thursday, July 31st. The shares were sold at an average price of $12.00, for a total transaction of $119,856.00. Following the sale, the chief executive officer directly owned 4,598,388 shares in the company, valued at $55,180,656. This trade represents a 0.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In the last 90 days, insiders have sold 831,310 shares of company stock worth $10,428,922. 23.19% of the stock is owned by company insiders.

UiPath Stock Performance

Shares of UiPath stock traded up $0.31 on Monday, hitting $11.80. 15,988,423 shares of the company's stock were exchanged, compared to its average volume of 11,748,976. The company has a 50-day simple moving average of $11.74 and a 200-day simple moving average of $11.79. The stock has a market capitalization of $6.31 billion, a PE ratio of 393.27, a PEG ratio of 12.07 and a beta of 1.02. UiPath, Inc. has a 1 year low of $9.38 and a 1 year high of $15.93.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Thursday, September 4th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.07. The business had revenue of $361.73 million for the quarter, compared to analysts' expectations of $347.36 million. UiPath had a net margin of 1.35% and a return on equity of 1.27%. The company's revenue was up 14.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.04 EPS. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, analysts expect that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.